BEX2 |
Q9BXY8
|
brain expressed X-linked 2
|
|
0.10 |
0.705 |
0.231 |
WDR45B |
Q5MNZ6
|
WD repeat domain 45B
|
|
0.16 |
0.760 |
0.269 |
GRIN2C |
Q14957
|
glutamate ionotropic receptor NMDA type subunit 2C
|
Ion channel
|
2.3E-07 |
0.792 |
0.269 |
HEXD |
Q8WVB3
|
hexosaminidase D
|
|
4.3E-11 |
0.780 |
0.308 |
MPP2 |
Q14168
|
membrane palmitoylated protein 2
|
Enzyme
|
2.9E-07 |
0.780 |
0.308 |
BEX3 |
Q00994
|
brain expressed X-linked 3
|
|
0.62 |
0.780 |
0.346 |
LINGO1 |
Q96FE5
|
leucine rich repeat and Ig domain containing 1
|
Receptor
|
0.99 |
0.682 |
0.385 |
CMM |
|
cutaneous malignant melanoma/dysplastic nevus
|
|
|
0.670 |
0.385 |
TBC1D7 |
Q9P0N9
|
TBC1 domain family member 7
|
|
2.9E-12 |
0.729 |
0.385 |
YWHAB |
P31946
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
|
Chaperone
|
0.98 |
0.769 |
0.385 |
IH |
|
Hemihypertrophy
|
|
|
0.751 |
0.385 |
FECD3 |
|
Corneal dystrophy, Fuchs endothelial, 3
|
|
|
0.769 |
0.385 |
WDR45 |
Q9Y484
|
WD repeat domain 45
|
|
0.99 |
0.647 |
0.423 |
MIR147B |
|
microRNA 147b
|
|
|
0.736 |
0.423 |
RAP1GAP |
P47736
|
RAP1 GTPase activating protein
|
Enzyme modulator
|
0.84 |
0.626 |
0.500 |
ELOC |
Q15369
|
elongin C
|
Enzyme modulator
|
0.74 |
0.656 |
0.500 |
TRPC4 |
Q9UBN4
|
transient receptor potential cation channel subfamily C member 4
|
Ion channel
|
0.48 |
0.695 |
0.500 |
MARCHF10 |
Q8NA82
|
membrane associated ring-CH-type finger 10
|
|
3.3E-24 |
0.716 |
0.500 |
NEUROG2 |
Q9H2A3
|
neurogenin 2
|
Enzyme
|
0.81 |
0.716 |
0.500 |
PAK2 |
Q13177
|
p21 (RAC1) activated kinase 2
|
Kinase
|
0.97 |
0.653 |
0.538 |
DEPDC5 |
O75140
|
DEP domain containing 5, GATOR1 subcomplex subunit
|
Nucleic acid binding
|
0.12 |
0.631 |
0.538 |
PTPN4 |
P29074
|
protein tyrosine phosphatase non-receptor type 4
|
|
1.00 |
0.633 |
0.538 |
GLRX3 |
O76003
|
glutaredoxin 3
|
Enzyme
|
0.36 |
0.686 |
0.538 |
MYO1B |
O43795
|
myosin IB
|
Cellular structure
|
7.2E-05 |
0.691 |
0.538 |
SPINT1 |
O43278
|
serine peptidase inhibitor, Kunitz type 1
|
|
1.0E-05 |
0.570 |
0.577 |